We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$91.2B
AUM Growth
+$11.2B
Cap. Flow
+$2B
Cap. Flow %
2.19%
Top 10 Hldgs %
23.22%
Holding
3,971
New
387
Increased
1,763
Reduced
1,480
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 14.58%
2 Healthcare 8.49%
3 Financials 8.3%
4 Consumer Discretionary 6.61%
5 Industrials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTR icon
701
Avantor
AVTR
$9.31B
$16.6M 0.02%
589,223
+169,162
+40% +$4.36M
ICLN icon
702
iShares Global Clean Energy ETF
ICLN
$2.09B
$16.5M 0.02%
585,225
+177,696
+44% +$3.99M
DWAS icon
703
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$445M
$16.5M 0.02%
219,072
+4,629
+2% +$315K
DOX icon
704
Amdocs
DOX
$6.1B
$16.5M 0.02%
232,024
+71,475
+45% +$4.49M
SONY icon
705
Sony
SONY
$138B
$16.4M 0.02%
812,850
+32,570
+4% +$566K
ALLE icon
706
Allegion
ALLE
$14.3B
$16.4M 0.02%
140,857
+25,243
+22% +$2.74M
TECH icon
707
Bio-Techne
TECH
$11.2B
$16.4M 0.02%
206,468
+19,316
+10% +$1.4M
VV icon
708
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$16.4M 0.02%
93,138
+8,619
+10% +$1.43M
BAH icon
709
Booz Allen Hamilton
BAH
$9.45B
$16.3M 0.02%
186,902
-9,800
-5% -$833K
WST icon
710
West Pharmaceutical
WST
$24.7B
$16.3M 0.02%
57,430
-2,422
-4% -$680K
GNRC icon
711
Generac Holdings
GNRC
$12.7B
$16.2M 0.02%
71,420
+10,038
+16% +$2.16M
EFV icon
712
iShares MSCI EAFE Value ETF
EFV
$30B
$16.2M 0.02%
343,507
+259,351
+308% +$11.4M
RPD icon
713
Rapid7
RPD
$902M
$16.2M 0.02%
179,621
-148,712
-45% -$10.6M
MANH icon
714
Manhattan Associates
MANH
$11.4B
$16.2M 0.02%
153,835
+408
+0.3% +$40.2K
CTVA icon
715
Corteva
CTVA
$50.9B
$16.2M 0.02%
417,307
+17,675
+4% +$632K
GEN icon
716
Gen Digital
GEN
$17.4B
$16.1M 0.02%
777,077
-93,103
-11% -$1.88M
ICLR icon
717
Icon
ICLR
$12.8B
$16.1M 0.02%
82,741
-2,678
-3% -$524K
IYH icon
718
iShares US Healthcare ETF
IYH
$3.76B
$16.1M 0.02%
327,945
+16,750
+5% +$791K
SSD icon
719
Simpson Manufacturing
SSD
$8.19B
$16.1M 0.02%
172,585
+2,665
+2% +$248K
CTAS icon
720
Cintas
CTAS
$82.1B
$16.1M 0.02%
182,332
+22,272
+14% +$1.93M
JD icon
721
JD.com
JD
$43.1B
$16.1M 0.02%
183,046
+32,461
+22% +$2.71M
CUB
722
DELISTED
Cubic Corporation
CUB
$16M 0.02%
257,856
-65,861
-20% -$4M
LCII icon
723
LCI Industries
LCII
$2.61B
$16M 0.02%
123,008
-2,277
-2% -$280K
WTRG icon
724
Essential Utilities
WTRG
$11.4B
$15.9M 0.02%
336,598
+26,869
+9% +$1.19M
VOE icon
725
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$15.8M 0.02%
132,574
+15,012
+13% +$1.68M

Similar funds

Raymond James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Raymond James & Associates held 3,971 positions worth $91.2B, up 14% from $80B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2020 filing shows 387 new, 1,763 increased, 1,480 reduced and 217 closed positions. Its largest new stake was Bentley Systems: 330,402 shares worth $13.4M. The largest sale was United Parcel Service, an estimated $69.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2020 buy was Bentley Systems: 330,402 shares worth $13.4M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $158M increase.
  • Raymond James & Associates's biggest Q4 2020 reduction was United Parcel Service, cutting an estimated $69.6M.
  • Raymond James & Associates fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q4 2020, selling an estimated $54.2M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $91.2B portfolio in Q4 2020.
  • Raymond James & Associates opened 387 new positions and closed 217 in Q4 2020.
  • Raymond James & Associates's portfolio value rose 14% quarter-over-quarter to $91.2B.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.